ask="55.39"
ask_size="200"
average_daily_volume="980231"
bid="51.00"
bid_size="100"
book_value="10.71"
change="+0.77"
change_from_200_day_moving_average="6.99"
change_from_50_day_moving_average="8.08"
change_from_52_week_high="-24.86"
change_From_52_week_low="23.87"
change_in_percent="+1.41%"
close="55.25"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.79"
ebitda="-409.46M"
eps_estimate_current_year="-5.08"
eps_estimate_next_quarter="-1.31"
eps_estimate_next_year="-4.69"
ex_dividend_date="N/A"
float_shares="71077000"
high="56.27"
high_52_weeks="80.11"
last_trade_date="3/17/2017"
last_trade_price="55.25"
last_trade_size="100"
last_trade_time="4:00pm"
low="50.31"
low_52_weeks="31.38"
market_capitalization="4.75B"
moving_average_200_day="48.26"
moving_average_50_day="47.17"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="66.40"
open="50.70"
pe_ratio="N/A"
peg_ratio="-0.23"
percent_change_from_200_day_moving_average="+14.49%"
percent_change_from_50_day_moving_average="+17.12%"
percent_change_from_52_week_high="-31.03%"
percent_change_from_52_week_low="+76.07%"
previous_close="54.48"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.09"
price_per_sales="99.37"
revenue="47.16M"
shares_outstanding="86013000"
short_ratio="11.04"
stock_exchange="NMS"
symbol="ALNY"
volume="4863078"
weeks_range_52="31.38 - 80.11"
